Abstract:The binding interactions of bisphenol A (BPA) and its halogenated derivatives (halogenated BPAs) to human estrogen receptor α ligand binding domain (hERα-LBD) was investigated using a combined in vitro and in silico approach. First, the recombinant hERα-LBD was prepared as a soluble protein in Escherichia coli BL21(DE3)pLysS. A native fluorescent phytoestrogen, coumestrol, was employed as tracer for the fluorescence polarization assay. The results of the in vitro binding assay showed that bisphenol compounds could bind to hERα-LBD as the affinity ligands. All the tested halogenated BPAs exhibited weaker receptor binding than BPA, which might be explained by the steric effect of substituents. Molecular docking studies elucidated that the halogenated BPAs adopted different conformations in the flexible hydrophobic ligand binding pocket (LBP), which is mainly dependent on their distinct halogenation patterns. The compounds with halogen substituents on the phenolic rings and on the bridging alkyl moiety acted as agonists and antagonists for hERα, respectively. Interestingly, all the compounds in the agonist conformation of hERα formed a hydrogen bond with His524, while the compounds in the antagonist conformation formed a hydrogen bond with Thr347. These docking results suggested a pivotal role of His524/Thr347 in maintaining the hERα structure in the biologically active agonist/antagonist conformation. Comparison of the calculated binding energies vs. experimental binding affinities yielded a good correlation, which might be applicable for the structure-based design of novel bisphenol compounds with reduced toxicities and for environmental risk assessment. In addition, based on hERα-LBD as a recognition element, the proposed fluorescence polarization assay may offer an alternative to chromatographic techniques for the multi-residue determination of bisphenol compounds.

Comparative study of the interactions between bisphenol analogues and serum albumins by electrospray mass spectrometry and fluorescence spectroscopy.

Impacts of Halogen Substitutions on Bisphenol A Compounds Interaction with Human Serum Albumin: Exploring from Spectroscopic Techniques and Computer Simulations

Interactions of three bisphenol analogues with hemoglobin investigated by spectroscopy and molecular docking

Binding of bisphenol A and acrylamide to BSA and DNA: insights into the comparative interactions of harmful chemicals with functional biomacromolecules.

Investigation of the interaction between endocrine disruptor bisphenol A and human serum albumin

Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies.

Molecular structural heterogeneity of bisphenols governs their serum albumin binding

Study of in vitro interaction between tetrabromobisphenol A and bovine serum albumin by fluorescence spectroscopy.

Direct interactions in the recognition between the environmental estrogen bisphenol AF and human serum albumin.

Probing the Binding of an Endocrine Disrupting Compound-Bisphenol F to Human Serum Albumin: Insights into the Interactions of Harmful Chemicals with Functional Biomacromolecules

Interactions Between Polybrominated Diphenyl Ethers And Human Serum Albumin Using Spr And Molecular Docking

Estrogenicity of halogenated bisphenol A: in vitro and in silico investigations

The Molecular Mechanism of Bisphenol A (BPA) As an Endocrine Disruptor by Interacting with Nuclear Receptors: Insights from Molecular Dynamics (MD) Simulations.

Interactions of Acidic Pharmaceuticals with Human Serum Albumin: Insights into the Molecular Toxicity of Emerging Pollutants

In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors

Spectroscopic and Molecular Modeling Approaches to Investigate the Interaction of Bisphenol A, Bisphenol F and Their Diglycidyl Ethers with PPARα.

Toxic Interaction Between Dibutyl Phthalate and Human Serum Albumin: Spectroscopic and Molecular Modeling Investigations

Quantification of bisphenol A and its selected analogs in serum using pre‐column derivatization with high‐performance liquid chromatography and tandem mass spectrometry

Correction to “thyroid Disruption by Bisphenol S Analogues Via Thyroid Hormone Receptor Β: in Vitro, in Vivo, and Molecular Dynamics Simulation Study”

Interaction of Bisphenol A 3, 4-Quinone Metabolite with Human Hemoglobin, Human Serum Albumin and Cytochrome C in Vitro.

Binding of phthalate plasticizers to human serum albumin in vitro: a multispectroscopic approach and molecular modeling.